Merative L.P., formerly IBM Watson Health, is an American medical technology company that provides products and services that help clients facilitate medical research, clinical research, real world evidence, and healthcare services, through the use of artificial intelligence, data analytics, cloud computing, and other advanced information technology.

As of 2023[update], it remains a standalone company headquartered in Ann Arbor with innovation centers in Ireland, Hyderabad, Bengaluru, and Chennai.

[2] On June 6, 2012, the sale was finalized and the new company, Truven Health Analytics, became an independent organization solely focused on healthcare.

[7] In January 2022, IBM announced the sale of part of the Watson Health assets, including Truven to Francisco Partners for a reported $1 billion.

[8] On June 30, 2022, Francisco Partners announced the completion of acquiring Watson Health and launched a healthcare data company named Merative.

[13] In February 2011, it was announced that IBM would be partnering with Nuance Communications for a research project to develop a commercial product during the next 18 to 24 months, designed to exploit Watson's clinical decision support capabilities.

And also, physicians at the University of Maryland would work to identify the best way that a technology like Watson could interact with medical practitioners to provide the maximum assistance.

[14] In September 2011, IBM and WellPoint (now Anthem) announced a partnership to utilize Watson's data crunching capability to help suggest treatment options to physicians.

The company has sent Watson to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, where it will increase its health expertise and assist medical professionals in treating patients.

[26] Several startups in the healthcare space have been effectively using seven business model archetypes to take solutions[buzzword] based on IBM Watson to the marketplace.

[27] In 2019, Eliza Strickland calls "the Watson Health story [...] a cautionary tale of hubris and hype" and provides a "representative sample of projects" with their status.

[36] In May 2017, IBM and Rensselaer Polytechnic Institute began a joint project entitled Health Empowerment by Analytics, Learning and Semantics (HEALS), to be explored using AI technology to enhance healthcare.

[42] Artificial intelligence in healthcare is the use of complex algorithms and software to emulate human cognition in the analysis of complicated medical data.

Medical institutions such as The Mayo Clinic, Memorial Sloan Kettering Cancer Center,[45][46] and National Health Service,[47] have developed AI algorithms for their departments.

Additionally, hospitals are looking to AI solutions[buzzword] to support operational initiatives that increase cost saving, improve patient satisfaction, and satisfy their staffing and workforce needs.

[50] Companies are developing predictive analytics solutions[buzzword] that help healthcare managers improve business operations through increasing utilization, decreasing patient boarding, reducing length of stay and optimizing staffing levels.

[53][54] Recent advances have suggested the use of AI to describe and evaluate the outcome of maxillo-facial surgery or the assessment of cleft palate therapy in regard to facial attractiveness or age appearance.

[55][56] In 2018, a paper published in the journal of Annals of Oncology mentioned that skin cancer could be detected more accurately by an artificial intelligence system (which used a deep learning convolutional neural network) than by dermatologists.

Efforts were consolidated in 2013 in the DDIExtraction Challenge, in which a team of researchers at Carlos III University assembled a corpus of literature on drug-drug interactions to form a standardized test for such algorithms.

[63][64][66] Other algorithms identify drug-drug interactions from patterns in user-generated content, especially electronic health records and/or adverse event reports.